Skip to main content

Table 5 Comparison of stress hormones in four groups (\( \overline{x}\pm s \))

From: The clinical effect of dexmedetomidine combined with parecoxib sodium on sedation, antianxiety and prevention of intubation stress in patients undergoing functional endoscopic sinus surgery: a randomised controlled trial

Measurements

Group

T0

T4

T6

E (ng/L)

D

198.8 ± 14.6

161.7 ± 12.1abc

194.3 ± 11.2ac

DP

201.4 ± 16.3

129.4 ± 10.7ab

166.7 ± 14.7a

P

193.0 ± 12.9

131.7 ± 11.7abc

188.7 ± 10.6ac

N

194.7 ± 13.9

195.9 ± 14.6c

243.6 ± 16.3bc

NE (ng/L)

D

332.8 ± 2.9

328.5 ± 2.4ab

333.5 ± 3.2ac

DP

331.9 ± 1.9

336.5 ± 2.1ab

337.5 ± 3.2a

P

333.4 ± 3.3

376.2 ± 3.1ab

433.3 ± 2.9ac

N

334.6 ± 2.1

385.9 ± 3.4c

441.6 ± 1.7bc

Cor (ng/mL)

D

239.5 ± 30.7

208.7 ± 37.6ab

244.7 ± 41.1a

DP

240.6 ± 35.1

199.1 ± 32.1ab

240.1 ± 40.3a

P

238.3 ± 33.6

209.8 ± 35.3ab

285.3 ± 44.7b

N

241.6 ± 35.1

240.4 ± 31.1c

292.1 ± 31.3bc

BS (mmol/L)

D

4.78 ± 0.26

4.31 ± 0.32ab

4.79 ± 0.28a

DP

4.75 ± 0.38

4.28 ± 0.24ab

4.57 ± 0.35a

P

4.71 ± 0.23

4.37 ± 0.42ab

4.77 ± 0.38a

N

4.76 ± 0.51

4.77 ± 0.62c

5.19 ± 0.56bc

  1. ap < 0.05 was compared with group N, bp < 0.05 was compared with T0, and cp < 0.05 was compared with group DP